...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

RENTSCHLER focuses on biotechnology and sells RENTSCHLER Pharma GmbH

| Print |
Wednesday, 09 July 2008 15:43 (UTC + 2)


Rentschler_logo

Laupheim, Germany, July 9, 2008 / b3c newswire / - RENTSCHLER will invest another 14 million Euro in the expansion of RENTSCHLER Biotechnologie GmbH at the Laupheim site. Only recently a 50 million Euro investment in biotechnological development and production facilities was completed.

The first sod will already be taken this year for the new construction of a logistics centre and the expansion of the administrative building in Erwin-Rentschler-Straße in Laupheim. In the logistics centre a high-rise warehouse, several cold warehouses, an incoming goods department, a dispatch area and the company's transport fleet will be located. The move into the new buildings is planned for end of 2009. With this step, Rentschler concentrates all of the biotech activities at one site and thus provides the frame for further growth.

Within the scope of this business concentration on the development and manufacture of biopharmaceutical drug products Dr. RENTSCHLER Holding GmbH & Co. KG has sold as per today all of the shares of RENTSCHLER Pharma GmbH to RIEMSER Arzneimittel AG in Greifswald/Isle of Riems, Eastern Germany.

RIEMSER is planning to further expand its business division contract manufacture from the Laupheim site. In this connection RENTSCHLER Pharma GmbH will be renamed to RIEMSER Speciality Production GmbH.

RENTSCHLER Biotechnologie GmbH
is an internationally operating contract organisation with many years of experience in the development, production and registration of drug products based on biopharmaceutical drug substances. The range of services of RENTSCHLER Biotechnologie GmbH also comprises the sterile filling of pre-filled syringes and injection vials. In Germany, the company employs more than 400 people.

 

The company RENTSCHLER, founded in 1927, concentrates its activities on the business sector biotechnology. RENTSCHLER Biotechnologie GmbH is a subsidiary of the medium-sized family-owned business Dr. RENTSCHLER Holding GmbH & Co. KG headquartered Laupheim, Baden-Wurttemberg, Germany.


For further information please contact:

Dr. Wieland W. Wolf
Rentschler Biotechnologie GmbH
Erwin-Rentschler Strasse 21
D 88471 Laupheim, Germany
Phone: +49/7392-701235
Fax: +49/7392-701220
E-Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it